A novel influenza subunit vaccine composed of liposome-encapsulated haemagglutinin/neuraminidase and IL-2 or GM-CSF. I. Vaccine characterization and efficacy studies in mice
- 12 February 1999
- Vol. 17 (9-10) , 1223-1238
- https://doi.org/10.1016/s0264-410x(98)00346-6
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Present Status of the Use of Cytokines as Adjuvants with Vaccines to Protect Against Infectious DiseasesClinical Infectious Diseases, 1995
- Cytokine-Containing Liposomes as Adjuvants for HIV Subunit VaccinesAIDS Research and Human Retroviruses, 1995
- Cytokines as Immunological AdjuvantsPublished by Springer Nature ,1995
- Liposome Design and Vaccine DevelopmentPublished by Springer Nature ,1995
- Cytokines as potential vaccine adjuvantsBiotherapy, 1994
- Liposomes as Immunoadjuvants and Vaccine Carriers: Antigen EntrapmentImmunoMethods, 1994
- Enhancement of the protective effect of inactivated influenza virus vaccine by cytokinesVaccine, 1992
- Failure of influenza vaccination in the agedJournal of Medical Virology, 1988
- IMPACT OF EPIDEMIC TYPE A INFLUENZA IN A DEFINED ADULT POPULATIONAmerican Journal of Epidemiology, 1980
- INFLUENZA A AND B VIRUS INFECTION IN INFANTS AND YOUNG CHILDREN DURING THE YEARS 1957–19761American Journal of Epidemiology, 1979